Evidence map›Paper›PMID 33392234›Full record

ArticleFrontiers in medicine2020

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease.

Konstantin Kazankov, Chiara Rosso, Ramy Younes, Angelo Armandi, Hannes Hagström, Holger Jon Møller, Per Stål, Elisabetta Bugianesi, Henning Grønbæk

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Konstantin KazankovDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Chiara RossoDepartment of Medical Sciences, Division of Gastroenterology and Hepatology, University of Turin, Turin, Italy.
Ramy YounesBoehringer Ingelheim International, Gesellschaft mit beschränkter Haftung, Ingelheim, Germany.
Angelo ArmandiDepartment of Medical Sciences, Division of Gastroenterology and Hepatology, University of Turin, Turin, Italy.
Hannes HagströmDepartment of Upper GI, Unit of Hepatology, Karolinska University Hospital, Stockholm, Sweden.
Holger Jon MøllerDepartment of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
Per StålDepartment of Upper GI, Unit of Hepatology, Karolinska University Hospital, Stockholm, Sweden.
Elisabetta BugianesiDepartment of Medical Sciences, Division of Gastroenterology and Hepatology, University of Turin, Turin, Italy.
Henning GrønbækDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKUniversity of Turin · ITBoehringer Ingelheim (Germany) · DEKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerscirrhosisFibroscanmacrophagesNAFLD

Identifiers

PMID33392234
PMCPMC7775526
OpenAlexW3111129520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.